Detalhe da pesquisa
1.
Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.
N Engl J Med
; 388(14): 1296-1306, 2023 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37018493
2.
Twice-Daily Dolutegravir Based Antiretroviral Therapy with One Month of Daily Rifapentine and Isoniazid (1HP) for TB Prevention.
Clin Infect Dis
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38568956
3.
Filling in the Gaps: Updates on Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections.
Clin Infect Dis
; 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38332660
4.
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
N Engl J Med
; 384(9): 795-807, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306283
5.
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
J Infect Dis
; 228(12): 1662-1666, 2023 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561027
6.
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
Clin Infect Dis
; 77(4): 560-564, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036397
7.
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study.
Ann Intern Med
; 175(9): 1221-1229, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35939812
8.
Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus.
Clin Infect Dis
; 73(2): e485-e493, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668455
9.
Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplant.
Am J Transplant
; 21(5): 1780-1788, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33277801
10.
Postexposure Doxycycline for Sexually Transmitted Infections. Reply.
N Engl J Med
; 389(3): 286-287, 2023 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467511
11.
High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence.
Am J Gastroenterol
; 116(9): 1896-1904, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34465693
12.
Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections.
Clin Infect Dis
; 70(6): 1247-1253, 2020 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31504345
13.
Risk of antimicrobial resistance with doxy-PEP is real, as is the need for its well-Informed implementation.
Clin Infect Dis
; 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38501192
14.
Ethical Considerations in Implementing Doxycycline Postexposure Prophylaxis for the Prevention of Bacterial Sexually Transmitted Infections.
Sex Transm Dis
; 51(3): 135-138, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38079243
15.
Direct-acting antiviral treatment for HIV/HCV patients in safety net settings: patient and provider preferences.
AIDS Care
; 31(11): 1340-1347, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30829533
16.
HCV treatment barriers among HIV/HCV co-infected patients in the US: a qualitative study to understand low uptake among marginalized populations in the DAA era.
J Public Health (Oxf)
; 41(4): e283-e289, 2019 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31044248
17.
Daily second-generation INSTIs and short-course TPT: What more do we need to know?
Clin Infect Dis
; 2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051645
18.
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study.
Clin Infect Dis
; 67(7): 1010-1017, 2018 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29566246
19.
Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trials.
Liver Int
; 38(6): 1010-1021, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29091342
20.
12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens.
Clin Infect Dis
; 62(12): 1489-96, 2016 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27025835